tiprankstipranks
Vertex Pharmaceuticals (GB:0QZU)
LSE:0QZU

Vertex Pharmaceuticals (0QZU) Stock Investors

9 Followers
Based on 730,435 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.5% of all portfolios hold GB:0QZU
On average, investors allocate 3.63% of their portfolios to GB:0QZU
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 730,435 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 0QZU

>0.1%
Last 7
Days
1.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GB:0QZU, out of 730,435 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

0QZU Investor Activity

No data currently available
Based on the activity of 13,718 investors who made their portfolios public
The table shows changes in 0QZU in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

0QZU Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Trade Desk
4.63%
-0.03%
-4.95%
39.64B
Technology
Merck & Company
4.12%
+0.09%
-1.16%
321.34B
Healthcare
ServiceNow
4.04%
+0.55%
-2.72%
151.89B
Technology
Block
4.51%
-0.83%
-7.83%
46.31B
Technology
Mercadolibre
5.27%
-0.71%
-2.75%
70.72B
Consumer Cyclical
Micron
5.71%
+0.54%
+7.08%
124.53B
Technology
Salesforce
4.95%
+0.46%
+0.59%
268.38B
Technology
Qualcomm
4.78%
-0.85%
-6.43%
180.07B
Technology
Mastercard
4.77%
+0.26%
-1.33%
431.76B
Financial
Cisco Systems
4.53%
-0.14%
-4.39%
195.66B
Technology
Based on the activity of 730,435 active portfolios
Open your Smart Portfolio

0QZU Investor Analysis

GB:0QZU investors under 35

Under 35

5.5%
Last 30 days
Holdings Change
12.1%
of GB:0QZU holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
GB:0QZU investors between 35–55

Between 35–55

10.2%
Last 30 days
Holdings Change
45.4%
of GB:0QZU holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
GB:0QZU investors over 55

Over 55

6.9%
Last 30 days
Holdings Change
42.5%
of GB:0QZU holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of GB:0QZU stock investors
See who invests in 0QZU according to age group and performance.

FAQ

How many retail Investors hold GB:0QZU?
0.5% of TipRanks' retail investors hold GB:0QZU in their portfolios.
    What is GB:0QZU Investor Sentiment?
    GB:0QZU’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of GB:0QZU in the last 7 days?
      >0.1% of TipRanks' retail investors changed their holding of GB:0QZU in the last 7 days.
        What percentage of retail investors changed their holding of GB:0QZU in the last 30 days?
        ▼ 1.5% of TipRanks' retail investors changed their holding of GB:0QZU in the last 30 days.
          What is the average age of retail investors who hold GB:0QZU?
          The average age of GB:0QZU Holders is between 35–55.
            What other stocks have GB:0QZU investors also bought?
            GB:0QZU Investors also bought TTD, MRK, NOW, SQ, MELI, MU, CRM, QCOM, MA, CSCO.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              GERNGeron
              HCAHCA Healthcare
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis